Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome
- 4 May 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 337 (8749) , 1071-1074
- https://doi.org/10.1016/0140-6736(91)91717-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: A spectrum of sclerodermatous skin diseaseJournal of the American Academy of Dermatology, 1990
- Eosinophilia-Myalgia SyndromeJAMA, 1990
- The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated withL-Tryptophan IngestionAnnals of Internal Medicine, 1990
- L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and FasciitisMedicine, 1990
- Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndromeSeminars in Arthritis and Rheumatism, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- L-tryptophan and eosinophilia-myalgia syndrome in New MexicoThe Lancet, 1990
- Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 casesPublished by Elsevier ,1988
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983